How should U.S. drug developers think about China? What will happen to the Food and Drug Administration under the Trump administration? What is the future of efforts to make clinical trials more diverse?
Also: Bill Nye, the Science Guy whose educational program inspired a generation of researchers, doctors, and biotech executives, will join us onstage for a discussion about rare diseases and, specifically, ataxia, a movement disorder that runs in his family. He didn't have children because he was afraid he would pass the disease to them.
This year's NYC summit will focus on how medical R&D can change the world — and how the field is rapidly changing. Among the confirmed speakers: Jim Wilson, a pioneer in gene therapy; Holly Fernandez Lynch, one of the most prominent outside voices on the FDA; and Ken Song, whose last company sold to Bristol Myers Squibb for $4.1 billion.
Join us for a full day of important and inspiring discussions! I hope to see you there.
Matt Herper
Editorial Director of Events, STAT
LIMITED PASSES AVAILABLE
Secure your Breakthrough East pass today
Join us live in New York City or online on March 20, 2025!
No comments